Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the design of modulators targeting neurotransmitter receptors due to the presence of constrained ring systems and fluorinated motifs that enhance metabolic stability and blood-brain barrier penetration. Commonly employed in medicinal chemistry for optimizing lead compounds in neurodegenerative disease and psychiatric disorder programs. Also utilized in the preparation of selective enzyme inhibitors where the azetidine-piperidine scaffold contributes to improved binding affinity and pharmacokinetic properties.